can be used with any Veress needle and provides tactile feedback representing the fascia and peritoneum as the needle traverses these sequential layers. The cost of the model is approximately $20 USD. The model is easily transportable, can accommodate practice from multiple learners during a single session, and is reusable. CONCLUSION: A low-cost, low-tech, portable and reusable Veress needle entry model can be a useful adjunct to facilitate instruction of trainees in closed laparoscopic entry.
OBJECTIVES:
To review the key surgical steps of repair of a rectovaginal cloacal defect. DESCRIPTION: In this video, a case is presented involving of the surgical management of an acquired chronic rectovaginal cloacal defect. A cloacal defect may occur secondary to breakdown of a 4th degree perineal laceration. Patients often present with fecal incontinence and dyspareunia. Examination will reveal complete absence of the perineal body and retraction of the external anal sphincters, resulting in the appearance of the classic "dovetail sign." The posterior vaginal epithelium will abut the anterior anal mucosa above the level of the hymenal ring. The surgical steps in repair of a rectovaginal cloacal defect include the following: sharp dissection between the posterior vaginal subepithelial tissue and the anterior anal mucosal wall, closure of the anal mucosa, reapproximation of the internal anal sphincter, external anal sphincterplasty, and finally a distal rectocele repair with perineorrhaphy. CONCLUSION: This surgical technique demonstrates how a directed sequential reapproximation of the anatomic structures successfully reconstructs perineal anatomy in a patient with a longstanding cloacal defect.
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OBJECTIVES:
To illustrate technique for the planned total laparoscopic hysterectomy of a morbidly obese patient with a cesarean scar ectopic pregnancy. DESCRIPTION: The case report involves a 37-year-old G3P2002 at 8 weeks 3 days gestation referred to an academic tertiary care hospital for management of a cesarean scar ectopic pregnancy identified on an outside dating scan. She had two prior low transverse cesarean sections. The patient initially opted for a trial of systemic methotrexate and intra-sac potassium chloride injection. The injection, however, was unsuccessful as the gestational sac could not be accessed. The patient did not desire future fertility, and subsequently elected to undergo total laparoscopic hysterectomy with bilateral salpingectomy (TLH/BS) at 9 weeks 6 days. This video illustrates techniques used to perform a total laparoscopic hysterectomy in the setting of a large ballooning cesarean scar ectopic. Tips and tricks for use of an ultrasonic scalpel are contained in the video. Key points include traction counter traction technique, gentle blunt brushing to dissect and mobilize the bladder, and approaching abnormal anatomy in a lateral to medial fashion. Total operative time was 168 minutes. Blood loss was 500 cc. Uterine weight was 259 grams. A 2x2 cm defect was noted in the anterior myometrium. One month postoperatively, the patient had recovered well from surgery. She was seeing a therapist and had joined a pregnancy loss support group to help manage her depression. CONCLUSION: Cesarean scar ectopic pregnancy is a rare yet lifethreatening condition that requires immediate clinical attention. Multiple medical and surgical treatment options exist, but the only definitive treatment remains hysterectomy. TLH/BS offers a minimally invasive approach that is safe, efficient and can be performed on an outpatient basis with low morbidity even in patients with morbid or super obesity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS:
Laura Young: Nothing to disclose; Kelly Kasper: Nothing to disclose.
61 Robotic-assisted debulking of pelvic and paraaortic lymph nodes
M. AlHilli, C. M. Michener
Cleveland Clinic, Cleveland, OH OBJECTIVES: To describe the technique in performing robotic-assisted pelvic and paraaortic lymph node debulking. DESCRIPTION: Patients with advanced cervical carcinoma and bulky macroscopic lymph nodes (>2cm; extracapsular spread) have a poor prognosis. These patients are treated with primary chemoradiation. Pretreatment surgical resection of bulky lymph nodes allows effective delivery of radiation to areas of lower volume disease. Available data demonstrate that survival in patients with completely resected macroscopic lymph node metastases is similar to that of patients with microscopic lymph node metastases. This video shows a 41 year old patient with stage IB2 cervical carcinoma (5cm, deep cervical stromal invasion).PET/CT and MRI showed multiple hypermetabolic bulky lymph nodes. She underwent robotic-assisted pelvic and paraaortic lymph node debulking without intraoperative or postoperative complications. She received weekly cisplatin with external beam radiation therapy to the pelvic and paraaortic lymph node basins followed by HDR brachytherapy. Following 13 months of surveillance, imaging demonstrated disease recurrence within the retrocrural/diaphragmatic region. Key steps in performing difficult lymphadenectomy include:
1. Careful retroperitoneal dissection and exposure of avascular pelvic spaces (pararectal and paravesical spaces).
2. Identification and isolation of important anatomic structures (ureters, obturator nerve and vessels, external and common iliac vessels, IVC).
3. Exposure of the medial and lateral borders of large vessels prior to resection of matted lymph nodes. 
